<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This study aimed to assess the inhibitory activities of <z:chebi fb="43" ids="17790">methanol</z:chebi> extracts from the microalgae Ankistrodesmus convolutus, Synechococcus elongatus, and Spirulina platensis against Epstein-Barr virus (EBV) in three Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) cell lines, namely Akata, B95-8, and P3HR-1 </plain></SENT>
<SENT sid="1" pm="."><plain>The antiviral activity was assessed by quantifying the cell-free EBV DNA using real-time polymerase chain reaction (PCR) technique </plain></SENT>
<SENT sid="2" pm="."><plain>The <z:chebi fb="43" ids="17790">methanol</z:chebi> extracts from Ankistrodesmus convolutus and Synechococcus elongatus displayed low cytotoxicity and potent effect in reducing cell-free EBV DNA (EC(50)&lt;0.01 µg/ml) with a high therapeutic index (&gt;28000) </plain></SENT>
<SENT sid="3" pm="."><plain>After fractionation by column chromatography, the fraction from Synechococcus elongatus (SEF1) reduced the cell-free EBV DNA most effectively (EC(50)=2.9 µg/ml, therapeutic index&gt;69) </plain></SENT>
<SENT sid="4" pm="."><plain>Upon further fractionation by high performance liquid chromatography (HPLC), the sub-fraction SEF1'a was most active in reducing the cell-free EBV DNA (EC(50)=1.38 µg/ml, therapeutic index&gt;14.5) </plain></SENT>
<SENT sid="5" pm="."><plain>This study suggests that microalgae could be a potential source of antiviral compounds that can be used against EBV </plain></SENT>
</text></document>